Microsoft Strikes Landmark Soil Carbon Credit Deal With Indigo Carbon to Boost Carbon-Negative Goal 
Federal Judge Clears Way for Jury Trial in Elon Musk’s Fraud Lawsuit Against OpenAI and Microsoft 
U.S. Transportation Board Sends Union Pacific–Norfolk Southern Merger Back for Revision 
White House Pressures PJM to Act as Data Center Energy Demand Threatens Grid Reliability 
U.S. Moves to Expand Chevron License and Control Venezuelan Oil Sales 
Walmart International CEO Kathryn McLay to Step Down After Two and a Half Years 
xAI Restricts Grok Image Editing After Sexualized AI Images Trigger Global Scrutiny 
Zhipu AI Launches GLM-Image Model Trained on Huawei Chips, Boosting China’s AI Self-Reliance Drive 
Google Seeks Delay on Data-Sharing Order as It Appeals Landmark Antitrust Ruling 
Anthropic Appoints Former Microsoft Executive Irina Ghose to Lead India Expansion 
U.S. Lawmakers Raise Alarm Over Trump Approval of Nvidia AI Chip Sales to China 
China’s AI Models Narrow the Gap With the West, Says Google DeepMind CEO 
China Halts Shipments of Nvidia H200 AI Chips, Forcing Suppliers to Pause Production 
Sanofi Gains China Approval for Myqorzo and Redemplo, Strengthening Rare Disease Portfolio 
Boeing Reaches Tentative Labor Deal With SPEEA Workers After Spirit AeroSystems Acquisition 
BYD Shares Rise in Hong Kong on Reports of Battery Supply Talks With Ford 
Publishers Seek to Join Lawsuit Against Google Over Alleged AI Copyright Infringement 
Canada blocked bulk exports of prescription drugs to the US as it would cause or worsen a drug shortage at home.
The said importation from Canada is President Donald Trump's strategy of lowering some drug prices in the US, which he touted in his debate with President-elect Joe Biden.
Many Canadian drug suppliers opposed Trump's plan as it could lead to shortages,
The “Importation Prescription Drugs” rule in the US would allow licensed US pharmacists or wholesalers to import in bulk certain prescription drugs intended for the Canadian market.
According to Canada's Health Minister Patty Hajdu, companies will be required to provide information to assess existing or potential shortages, which could be as quick as within 24 hours if there is a serious or imminent health risk.
Hajdu emphasized the need for vigilance in maintaining the national drug supply noting that Canada is a small market, representing 2 percent of global drug sales, that sources 68 percent of its drugs internationally.
Canadian Prime Minister Justin Trudeau said in September that his priority was protecting the needs of Canadians in terms of pharmaceutical supplies.
